RCT in 2300 CABG patients: 3 months of ticagrelor plus aspirin then aspirin was non-inferior to 12 months for vein graft occlusion (10.8% vs 11.2% of grafts) and cut BARC 2, 3 or 5 bleeding (8.3% vs 13.2%); MACCE was similar.
RCTn = 2,300
Yuan et al. Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial